ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $920,586 | +16.2% | 42,600 | +4.2% | 0.00% | 0.0% |
Q3 2022 | $792,000 | -2.5% | 40,900 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $812,000 | -29.8% | 40,900 | +5.4% | 0.00% | 0.0% |
Q1 2022 | $1,157,000 | +38.1% | 38,800 | +7.8% | 0.00% | 0.0% |
Q4 2021 | $838,000 | -20.3% | 36,000 | +6.8% | 0.00% | 0.0% |
Q3 2021 | $1,051,000 | -11.4% | 33,700 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,186,000 | -3.6% | 33,700 | -3.4% | 0.00% | 0.0% |
Q1 2021 | $1,230,000 | -4.4% | 34,900 | +1.7% | 0.00% | 0.0% |
Q4 2020 | $1,287,000 | – | 34,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |